These agreements will be executed at its Spokane, Washington facility for contract manufacturing of products ranging from liquid to lyophilization presentations, across a variety of patient indications, the company said.
Commercial transfer to the Jubilant HollisterStier manufacturing facility has commenced for all contracts.
Jubilant HollisterStier CEO Marcelo Morales said this expansion of their globally leading parenteral manufacturing capabilities is a further outcome of their strategy to extend their offering across products and geographies.
"We are pleased to offer our support in the development and manufacture of highly complex products through the application of leading scientific solutions and utmost dedication to quality and customer service," Morales added.